If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaga Regulatory News (SAGA)

Share Price Information for Saga (SAGA)

Share Price is delayed by 15 minutes
Get Live Data
589.00    -42.00 (-6.66%)
Bid:
580.00
Ask:
583.00
Spread: 3.00 (0.517%)
Market Cap: £856.35m
SAGA Live PriceLast checked at - London Stock Exchange

Intraday Saga Share Chart

Holding(s) in Company

4 Jan 2016 10:00

RNS Number : 6302K
SAGA PLC
04 January 2016
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Saga Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

X

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

The Goldman Sachs Group, Inc.

4. Full name of shareholder(s)  (if different from 3.):iv

Goldman Sachs International

Goldman Sachs Asset Management, L.P.

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

29 December 2015

6. Date on which issuer notified:

31 December 2015

7. Threshold(s) that is/are crossed orreached: vi, vii

Below 3%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

 

GB00BLT1Y088

3,803,935

3,803,935

Below 3%

Below 3%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

Below 3%

Below 3%

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

Below 3%

Below 3%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

N/A

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

Please note, total amount of voting rights have been rounded to 2 decimal places therefore there is a possibility of a rounding error.

General email contact:

shareholderdisclosures@gs.com

14. Contact name:

Peter Chisholm

15. Contact telephone number:

+44 207 051 9612

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEASAFDEASFFF
Date   Source Headline
3rd Jul 20183:40 pmRNSDirector/PDMR Shareholding
21st Jun 20184:11 pmRNSResult of AGM
21st Jun 20187:00 amRNSAGM Trading Update
18th Jun 20184:16 pmRNSDirector/PDMR Shareholding
29th May 20187:00 amRNSDirector/PDMR Shareholding
23rd May 20184:15 pmRNSHolding(s) in Company
21st May 201810:23 amRNSNomination Committee Chairmanship changes
17th May 20182:42 pmRNSDirector/PDMR Shareholding
15th May 20183:20 pmRNSHolding(s) in Company
11th May 20187:00 amRNSNotice of AGM
4th May 20183:39 pmRNSHolding(s) in Company
4th May 20183:38 pmRNSDirector/PDMR Shareholding
20th Apr 20185:18 pmRNSHolding(s) in Company
18th Apr 20183:42 pmRNSHolding(s) in Company
18th Apr 20189:33 amRNSDirector/PDMR Shareholding
16th Apr 20187:25 amRNSDirector/PDMR Shareholding
16th Apr 20187:25 amRNSDirector/PDMR Shareholding
13th Apr 20183:29 pmRNSHolding(s) in Company
12th Apr 20187:00 amRNSPreliminary Results
11th Apr 20189:22 amRNSHolding(s) in Company
28th Mar 20187:00 amRNSDirectorate Change
22nd Mar 20184:12 pmRNSHolding(s) in Company
21st Mar 20183:22 pmRNSHolding(s) in Company
15th Mar 201812:34 pmRNSDirector/PDMR Shareholding
13th Mar 20184:01 pmRNSHolding(s) in Company
12th Mar 20182:40 pmRNSHolding(s) in Company
12th Mar 20189:24 amRNSHolding(s) in Company
9th Mar 20189:00 amRNSHolding(s) in Company
1st Mar 20183:11 pmRNSHolding(s) in Company
19th Feb 20182:57 pmRNSHolding(s) in Company
19th Feb 20187:00 amRNSAppointment of Patrick O'Sullivan as Chairman
16th Feb 20189:00 amRNSDirector/PDMR Shareholding
12th Feb 20187:00 amRNSNew quota share agreement with NewRe & Hannover Re
24th Jan 20187:00 amRNSDirector/PDMR Shareholding
23rd Jan 20183:28 pmRNSHolding(s) in Company
18th Jan 201811:51 amRNSDirector/PDMR Shareholding
12th Jan 20189:46 amRNSHolding(s) in Company
4th Jan 20187:00 amRNSGroup Executive Changes
3rd Jan 20184:05 pmRNSDirector Declaration
15th Dec 20173:21 pmRNSDirector/PDMR Shareholding
13th Dec 20177:00 amRNSDirector/PDMR Shareholding
12th Dec 20174:17 pmRNSHolding(s) in Company
7th Dec 20177:00 amRNSDirector/PDMR Shareholding
6th Dec 20177:00 amRNSTrading Update
21st Nov 20173:30 pmRNSDirector/PDMR Shareholding
20th Nov 20172:16 pmRNSDirector/PDMR Shareholding
16th Nov 20171:41 pmRNSDirector/PDMR Shareholding
24th Oct 20177:00 amRNSSaga Chairman announces intention to retire
18th Oct 20171:31 pmRNSHolding(s) in Company
17th Oct 20172:19 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.